logo

For the Inventor, By the Inventor

Menlo Park, CA, United States of America

David H Mack

This inventor holds 24 USPTO granted patents and 3 published patent applications, primarily in Cancer Diagnostics. Top assignees: Affymetrix, Inc., Eos Biotechnology, Inc., Protein Design Labs, Inc.. Active years: 2000-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David H Mack. Retrieved from https://idiyas.com/inventor/david-h-mack

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 

% Patents Active = 83.3

Average Co-Inventor Count = 2.5

ph-index = 11

Forward Citations = 627(Granted Patents)


Company Filing History:

goldMedal9 out of 561 
 
Affymetrix, Inc.
 patents
silverMedal6 out of 9 
 
Eos Biotechnology, Inc.
 patents
bronzeMedal4 out of 29 
 
Protein Design Labs, Inc.
 patents
4. 2 out of 20 
 
Pdl Biopharma, Inc.
 patents
5. 1 out of 13 
 
Abbott Biotherapeutics Corp.
 patents
6. 1 out of 628 
 
Cedars-Sinai Medical Center
 patents
7. 1 out of 5,515 
 
Leland Stanford Junior University
 patents
8. 1 out of 1,134 
 
Princeton University
 patents
9. 1 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 2000-2012

Loading Chart...
Areas of Expertise:
Cancer Diagnosis
Breast Cancer
Colorectal Cancer
Prostate Cancer
Ovarian Cancer
Nucleic Acid Arrays
Gene Expression
Microorganism Characterization
Cancer Modulators
Genetic Analysis
P53-Regulated Genes
Chip-Based Technologies
24 patents (USPTO):Explore Patents
1. 8313745 - Compositions against cancer antigen LIV-1 and uses thereof (2012-11-20),
2. 7736853 - Methods of diagnosis of androgen-dependent prostate cancer, prostate cancer undergoing androgen withdrawal, and androgen-independent prostate cancer (2010-06-15),
3. 7435589 - Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer (2008-10-14),
4. 7252948 - Chip-based speciation and phenotypic characterization of microorganisms (2007-08-07),
5. 7189507 - Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer (2007-03-13),
6. 6924094 - Chip-based species identification and phenotypic characterization of microorganisms (2005-08-02),
7. 6913882 - Methods of screening for B cell activity modulators (2005-07-05),
8. 6821724 - Methods of genetic analysis using nucleic acid arrays (2004-11-23),
9. 6780586 - Methods of diagnosing breast cancer (2004-08-24),
10. 6773878 - Methods of diagnosing of colorectal cancer, compositions, and methods of screening for colorectal cancer modulators (2004-08-10),
11. 6762020 - Methods of diagnosing breast cancer (2004-07-13),
12. 6750013 - Methods for detection and diagnosing of breast cancer (2004-06-15),
13. 6733969 - Expression monitoring for gene function identification (2004-05-11),
14. 6682890 - Methods of diagnosing and determining prognosis of colorectal cancer (2004-01-27),
15. 6649342 - Methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators (2003-11-18),

Title: The Innovations and Contributions of David H. Mack

Introduction

David H. Mack is a prominent inventor based in Menlo Park, California, known for his significant contributions to cancer research through his innovative patent portfolio. With a total of 24 patents to his name, Mack has focused on developing methods and compositions that advance the diagnosis and treatment of various cancers.

Latest Patents

Among his latest patents, Mack has developed compositions aimed at targeting the cancer antigen LIV-1, which are critical for both diagnosis and therapeutic interventions in cancer. Additionally, he has created methods for diagnosing different states of prostate cancer, detailing the expression patterns of genes that are up-regulated or down-regulated in both androgen-dependent and independent forms of the disease. His work also includes innovative approaches for identifying modulators of prostate cancer, particularly in drug-resistant cases.

Career Highlights

Throughout his career, David H. Mack has been associated with notable companies, including Affymetrix, Inc. and Eos Biotechnology, Inc. These experiences have allowed him to leverage his inventions within leading organizations in the biotechnology sector, enhancing research and therapeutic possibilities.

Collaborations

Mack's innovative journey has been further enhanced by collaborations with esteemed colleagues such as Kurt C. Gish and Keith E. Wilson. Through teamwork, they have collectively contributed to advancements in understanding and combating cancer, demonstrating the importance of collaboration in scientific research.

Conclusion

David H. Mack stands out as an influential inventor in the field of cancer research, with his numerous patents reflecting his dedication to improving diagnostic and treatment methods. His contributions not only advance scientific knowledge but also offer hope for better cancer management strategies in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…